Published in Biomed Res Int on April 15, 2015
Rho GTPases in cell biology. Nature (2002) 22.81
Identification of ubiquitin ligases required for skeletal muscle atrophy. Science (2001) 12.98
A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell (2009) 6.88
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation (2003) 5.85
Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell (2009) 5.18
Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndrome. Nat Genet (2006) 3.94
The organization of titin filaments in the half-sarcomere revealed by monoclonal antibodies in immunoelectron microscopy: a map of ten nonrepetitive epitopes starting at the Z line extends close to the M line. J Cell Biol (1988) 3.86
The kinase domain of titin controls muscle gene expression and protein turnover. Science (2005) 3.68
Role of citron kinase as a target of the small GTPase Rho in cytokinesis. Nature (1998) 3.55
CITRATE AS AN INTERMEDIARY IN THE INHIBITION OF PHOSPHOFRUCTOKINASE IN RAT HEART MUSCLE BY FATTY ACIDS, KETONE BODIES, PYRUVATE, DIABETES, AND STARVATION. Nature (1963) 3.32
Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation (2008) 2.93
Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase. Biochem J (1980) 2.79
Towards a molecular understanding of titin. EMBO J (1992) 2.78
A novel partner for the GTP-bound forms of rho and rac. FEBS Lett (1995) 2.52
Phosphofructokinase. Adv Enzymol Relat Areas Mol Biol (1979) 2.48
Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am J Physiol Heart Circ Physiol (2006) 2.37
The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ Res (2006) 2.29
Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat Genet (2002) 2.27
Mechanoenzymatics of titin kinase. Proc Natl Acad Sci U S A (2008) 2.17
Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet (2002) 2.14
The giant protein titin. Emerging roles in physiology and pathophysiology. Circ Res (1997) 2.14
MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J Mol Biol (2005) 2.13
Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology (2013) 2.09
Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J (2005) 2.07
Molecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytes. Am J Physiol Heart Circ Physiol (2007) 2.07
Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ Res (2007) 2.05
Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J Mol Biol (2001) 2.05
Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation (2000) 2.04
Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell (1993) 2.04
Population-based variation in cardiomyopathy genes. Circ Cardiovasc Genet (2012) 2.00
Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest (2013) 1.97
Muscle giants: molecular scaffolds in sarcomerogenesis. Physiol Rev (2009) 1.92
SmyD1, a histone methyltransferase, is required for myofibril organization and muscle contraction in zebrafish embryos. Proc Natl Acad Sci U S A (2006) 1.85
Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band: implications for hereditary myopathies. J Cell Sci (2008) 1.84
Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 1.83
Obscurin is a ligand for small ankyrin 1 in skeletal muscle. Mol Biol Cell (2003) 1.80
Catching a GEF by its tail. Trends Cell Biol (2006) 1.79
Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice. Hypertension (2007) 1.79
Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J Cell Sci (2002) 1.77
Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology (2005) 1.77
Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy. Circ Res (2002) 1.77
Calcium cycling proteins and heart failure: mechanisms and therapeutics. J Clin Invest (2013) 1.74
Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. Eur Heart J (2009) 1.73
The creatine kinase system and pleiotropic effects of creatine. Amino Acids (2011) 1.73
Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles. J Cell Biol (2003) 1.72
Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. J Clin Invest (2007) 1.70
Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation (2005) 1.67
Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy. Neurology (2004) 1.67
The M-band: an elastic web that crosslinks thick filaments in the center of the sarcomere. Trends Cell Biol (2005) 1.67
Gene mutations in apical hypertrophic cardiomyopathy. Circulation (2005) 1.64
Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A (1993) 1.62
Enolase isoenzymes in rat tissues. Electrophoretic, chromatographic, immunological and kinetic properties. Biochim Biophys Acta (1974) 1.61
Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci U S A (1992) 1.61
Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J (2007) 1.61
A novel MYH7 mutation links congenital fiber type disproportion and myosin storage myopathy. Neuromuscul Disord (2011) 1.55
Accelerated rates of glycolysis in the hypertrophied heart: are they a methodological artifact? Am J Physiol Endocrinol Metab (2002) 1.54
Phosphofructokinase deficiency; past, present and future. Curr Mol Med (2002) 1.52
Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation (2011) 1.51
Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly. J Biol Chem (2006) 1.50
Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1). Am J Hum Genet (2004) 1.50
The structure of the sarcomeric M band: localization of defined domains of myomesin, M-protein, and the 250-kD carboxy-terminal region of titin by immunoelectron microscopy. J Cell Biol (1996) 1.49
An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet (2008) 1.49
α-Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol (2012) 1.48
Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle. Proc Natl Acad Sci U S A (2010) 1.48
C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol (2007) 1.47
Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res (1998) 1.46
Proteomic analysis of organ-specific post-translational lysine-acetylation and -methylation in mice by use of anti-acetyllysine and -methyllysine mouse monoclonal antibodies. Proteomics (2005) 1.46
RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem (2007) 1.46
Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest (2008) 1.46
Regulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger protein. J Cell Biol (2000) 1.45
Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet (2009) 1.44
Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-a-half LIM domain 1 gene. Circ Cardiovasc Genet (2013) 1.43
Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis. J Mol Biol (2007) 1.41
The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. J Biol Chem (1998) 1.40
Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum. J Cell Sci (2009) 1.40
X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. Am J Hum Genet (2008) 1.40
Obscurin modulates the assembly and organization of sarcomeres and the sarcoplasmic reticulum. FASEB J (2006) 1.39
Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension (2007) 1.38
Localization and function of M-line-bound creatine kinase. M-band model and creatine phosphate shuttle. Cell Muscle Motil (1985) 1.34
Three-dimensional structure of the vertebrate muscle M-region. J Mol Biol (1978) 1.34
A review of animal phosphofructokinase isozymes with an emphasis on their physiological role. Mol Cell Biochem (1983) 1.33
Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1. Hum Mol Genet (2010) 1.32
Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest (1992) 1.30
Myosinopathies: pathology and mechanisms. Acta Neuropathol (2012) 1.29
Myosin storage myopathy associated with a heterozygous missense mutation in MYH7. Ann Neurol (2003) 1.29
Targeted disruption of the murine Bin1/Amphiphysin II gene does not disable endocytosis but results in embryonic cardiomyopathy with aberrant myofibril formation. Mol Cell Biol (2003) 1.26
One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region. Eur J Hum Genet (2005) 1.25
Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. J Biol Chem (2008) 1.25
Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62. J Biol Chem (2011) 1.24
Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ Cardiovasc Genet (2010) 1.24
A role for the putative tumor suppressor Bin1 in muscle cell differentiation. Mol Cell Biol (1998) 1.24
Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly. Mol Biol Cell (2009) 1.23
Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. EMBO J (2000) 1.23
Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection. J Biol Chem (2008) 1.23
Myomesin and M-protein: expression of two M-band proteins in pectoral muscle and heart during development. J Cell Biol (1985) 1.22
Alpha-cardiac myosin heavy chain (MYH6) mutations affecting myofibril formation are associated with congenital heart defects. Hum Mol Genet (2010) 1.22